Request for Covid-19 Impact Assessment of this Report
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
The global Insulin Glargine market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Single Dose Vial
Pre-filled Syringe
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Sanofi-Aventis
Ganlee
Biocon
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Treat type 1 diabetes
Treat type 2 diabetes
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Insulin Glargine Picture
1.1.2 Specifications
Table Product Specifications of Insulin Glargine
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Insulin Glargine
Table Global Insulin Glargine Market by Type, 2011-2022 (USD Million)
1.2.1.1 Single Dose Vial
Table Single Dose Vial Overview
1.2.1.2 Pre-filled Syringe
Table Pre-filled Syringe Overview
1.2.2 by Application
Table Application Segment of Insulin Glargine
Table Global Insulin Glargine Market by Application, 2011-2022 (USD Million)
1.2.2.1 Treat type 1 diabetes
Table Treat type 1 diabetes Overview
1.2.2.2 Treat type 2 diabetes
Table Treat type 2 diabetes Overview
1.2.3 by Regions
Table Global Insulin Glargine Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Insulin Glargine
2.2 Upstream
Table Cost of Insulin Glargine
Figure Manufacturing Process of Insulin Glargine
2.3 Market
2.3.1 SWOT
Figure SWOT of Insulin Glargine
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Insulin Glargine
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Insulin Glargine
3.4 Market Entry
Table Market Entry of Insulin Glargine
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Single Dose Vial Market, 2013-2018
Figure Single Dose Vial Market Size and Growth, 2012-2018 (USD Million)
Figure Single Dose Vial Market Size and Growth, 2012-2018 (in Volume)
Table Single Dose Vial CAGR by Revenue and Volume, 2012-2018
4.1.2 Pre-filled Syringe Market, 2013-2018
Figure Pre-filled Syringe Market Size and Growth, 2012-2018 (USD Million)
Figure Pre-filled Syringe Market Size and Growth, 2012-2018 (in Volume)
Table Pre-filled Syringe CAGR by Revenue and Volume, 2012-2018
4.2 Market Forecast
4.2.1 Single Dose Vial Market Forecast, 2020-2025
Figure Single Dose Vial Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Single Dose Vial Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Single Dose Vial CAGR by Revenue and Volume, 2012-2024
4.2.2 Pre-filled Syringe Market Forecast, 2020-2025
Figure Pre-filled Syringe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Pre-filled Syringe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Pre-filled Syringe CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Treat type 1 diabetes Market, 2013-2018
Figure Treat type 1 diabetes Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Treat type 1 diabetes CAGR by Revenue and Volume, 2012-2018
5.1.2 Treat type 2 diabetes Market, 2013-2018
Figure Treat type 2 diabetes Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Table Treat type 2 diabetes CAGR by Revenue and Volume, 2012-2018
5.2 Market Forecast
5.2.1 Treat type 1 diabetes Market Forecast, 2020-2025
Figure Treat type 1 diabetes Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Treat type 1 diabetes Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Treat type 1 diabetes CAGR by Revenue and Volume, 2020-2025
5.2.2 Treat type 2 diabetes Market Forecast, 2020-2025
Figure Treat type 2 diabetes Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Treat type 2 diabetes Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Treat type 2 diabetes CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Table North America CAGR by Revenue and Volume, 2012-2018
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Table Europe CAGR by Revenue and Volume, 2012-2018
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Table South America CAGR by Revenue and Volume, 2012-2018
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Insulin Glargine Market by Vendors, 2012-2018 (in Volume)
Table Global Insulin Glargine Market Share by Vendors, 2012-2018 (USD Million)
Table Global Insulin Glargine Market Share by Vendors, 2012-2018 (in Volume)
7.2 Market Concentration
Figure Insulin Glargine Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Sanofi-Aventis
Table Sanofi-Aventis Profile List
Table Microecological Modulator Operating Data of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Ganlee
Table Ganlee Profile List
Table Microecological Modulator Operating Data of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Biocon
Table Biocon Profile List
Table Microecological Modulator Operating Data of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Insulin Glargine
Table Products Segment of Insulin Glargine
Table Global Insulin Glargine Market by Type, 2011-2022 (USD Million)
Table Single Dose Vial Overview
Table Pre-filled Syringe Overview
Table Application Segment of Insulin Glargine
Table Global Insulin Glargine Market by Application, 2011-2022 (USD Million)
Table Treat type 1 diabetes Overview
Table Treat type 2 diabetes Overview
Table Global Insulin Glargine Market by Region, 2011-2022 (USD Million)
Table Cost of Insulin Glargine
Table Market Dynamics
Table Policy of Insulin Glargine
Table GDP of Major Countries
Table Technology of Insulin Glargine
Table Market Entry of Insulin Glargine
Table Single Dose Vial CAGR by Revenue and Volume, 2012-2018
Table Pre-filled Syringe CAGR by Revenue and Volume, 2012-2018
Table Single Dose Vial CAGR by Revenue and Volume, 2012-2024
Table Pre-filled Syringe CAGR by Revenue and Volume, 2012-2024
Table Treat type 1 diabetes CAGR by Revenue and Volume, 2012-2018
Table Treat type 2 diabetes CAGR by Revenue and Volume, 2012-2018
Table Treat type 1 diabetes CAGR by Revenue and Volume, 2020-2025
Table Treat type 2 diabetes CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018
Table North America CAGR by Revenue and Volume, 2012-2018
Table Europe CAGR by Revenue and Volume, 2012-2018
Table South America CAGR by Revenue and Volume, 2012-2018
Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Insulin Glargine Market by Vendors, 2012-2018 (in Volume)
Table Global Insulin Glargine Market Share by Vendors, 2012-2018 (USD Million)
Table Global Insulin Glargine Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Sanofi-Aventis Profile List
Table Microecological Modulator Operating Data of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Profile List
Table Microecological Modulator Operating Data of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Profile List
Table Microecological Modulator Operating Data of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...